Evidence map›Paper›PMID 35630296›Full record

ArticleMicroorganisms2022

Potential Probiotic

Youjin Lee, Pia Werlinger, Joo-Won Suh, Jinhua Cheng

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Cold-Adapted Uric Acid-DegradingMolecules (Basel, Switzerland) · 2026
    Article
  8. Article
  9. The Protective Effects and Underlying Mechanisms ofAnimals : an open access journal from MDPI · 2026
    Article
  10. Article
  11. Nutrients · 2025
    Article
  12. Foods (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Youjin LeeGraduate School of Interdisciplinary Program of Biomodulation, Myongji University, Yongin 17058, Korea.ORCID 0000-0002-3752-3871
Pia WerlingerGraduate School of Interdisciplinary Program of Biomodulation, Myongji University, Yongin 17058, Korea.
Joo-Won SuhMyongji Bioefficacy Research Center, Myongji University, Yongin 17058, Korea.
Jinhua ChengMyongji Bioefficacy Research Center, Myongji University, Yongin 17058, Korea.
Myongji University · KR

Funding

Rural Development Administration PJ01562101
6 · The paper itself

Abstract

Hyperuricemia is a metabolic disorder caused by increased uric acid (UA) synthesis or decreased UA excretion. Changes in eating habits have led to an increase in the consumption of purine-rich foods, which is closely related to hyperuricemia. Therefore, decreased purine absorption, increased UA excretion, and decreased UA synthesis are the main strategies to ameliorate hyperuricemia. This study aimed to screen the lactic acid bacteria (LAB) with purine degrading ability and examine the serum UA-lowering effect in a hyperuricemia mouse model. As a result,

Indexed as

hyperuricemiaL. paracasei MJM60396microbiotaprobioticspurine degradationtight junction proteinuric acidxanthine oxidase

Identifiers

PMID35630296
PMCPMC9146106
OpenAlexW4224262105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.